Hideaki Matsuoka, Ph.D.
Dr. Matsuoka worked as a research scientist in the fields of immunology, cell biology, and molecular biology and later moved to the venture management and scouting division in the United States. During his time in this position, he built business networks and engaged with innovator communities in the US and Japan. He assumed the Executive Director role in Modality Management in 2019. He has been in his present position since April 2020.
Principal Investigator* of Astellas
(Project Associate Professor, Gifu University)
Hiroki Ando, Ph.D.
* Principal Investigator (PI): One of the research professions at Astellas
Dr. Ando is an expert in synthetic biology and has been working to develop the next generation phage therapy technology. After graduating from the doctoral course at Osaka University, he studied novel drug resistance mechanisms in Mycobacterium tuberculosis as a Senior Researcher in the National Center for Global Health and Medicine. He then studied phage engineering platform and synthetic phages as a Research Scientist at Massachusetts Institute of Technology. In 2017, he became an Assistant Professor of the Graduate School of Medicine at Gifu University. In March 2020, he joined Astellas as a Principal Investigator.
Ando H, Lemire S, Pires DP, Lu TK.
Engineering Modular Viral Scaffolds for Targeted Bacterial Population Editing.
Cell Syst. 2015 Sep 23;1(3):187-196. doi: 10.1016/j.cels.2015.08.013.